Foot & Ankle Focus: The Use of Biologics in Foot and Ankle Surgery

Moderators: Sheldon S. Lin, MD, and Rick Brown, MD
Faculty: Samuel B. Adams, Jr., MD, James D. Calder, MD, MBBS, FFSEM, FRCS(Tr&Orth), PhD, Rod Jaques, MD

This is the first in a brand new series of webinars involving a unique collaboration between the American and British Orthopaedic Foot and Ankle Societies. Each interactive webinar seeks to challenge the status quo around complex or topical issues in our surgical discipline. We hear the differing viewpoints of respected experts from both sides of the Atlantic and both sides of the argument, brought to life through case discussion and jointly moderated Q&A sessions. This time the question is whether we should be using Biologics in our surgical practices.

At the conclusion of this webinar, you will be able to:

• Understand the mechanism of action and rationale behind the common modern Biologics
• Appreciate the evidence base and controversies relating to the use of Biologics in foot and ankle surgery
• Learn the practical applications of these surgical adjuncts 

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AOFAS designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information on AOFAS accreditation and education policies, visit the Program Overview page.

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.